Endogenous serotonin enhances the release of dopamine in the striatum only when nigro-striatal dopaminergic transmission is activated

Neuropharmacology

Volumn 39, Issue 11, 2000, Pages 1984-1995

  Lucas, Guillaume ^a   De Deurwaerdère, Philippe ^a   Porras, Grégory ^a   Spampinato, Umberto ^a  

^a CNRS   (France)

Author keywords

5,7 DHT; 5 HIAA outflow; Citalopram; DA release; Endogenous serotonin; Fluoxetine; Freely moving rats; Haloperidol; Halothane anaesthetized rats; Microdialysis; Striatum; WAY 100635

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CITALOPRAM; DOPAMINE; FLUOXETINE; HALOPERIDOL; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG EFFECT; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONINERGIC NERVE CELL; TISSUE LEVEL;

5,7-DIHYDROXYTRYPTAMINE; ANIMALS; CITALOPRAM; CORPUS STRIATUM; DOPAMINE; FLUOXETINE; HIPPOCAMPUS; HYDROXYINDOLEACETIC ACID; MALE; MICRODIALYSIS; PIPERAZINES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGENTS; SEROTONIN UPTAKE INHIBITORS; SUBSTANTIA NIGRA;

EID: 0033842215     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(00)00020-4     Document Type: Article

References (61)

1. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 38:1999;1083-1152.
2. Baumgarten H.C., Bjorklund A., Lackenmayer L., Nobin A. Evaluation of the effects of 5,7-dihydroxytryptamine on serotonin and catecholamine neurones in the rat CNS. Acta Physiologica Scandinavia. 391:1973;1-19.
3. Benloucif S., Galloway M.P. Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. European Journal of Pharmacology. 200:1991;1-8.
4. Besson M.J., Chéramy A., Feltz P., Glowinski J. Release of the newly synthetized dopamine from dopamine-containing terminals in the striatum of the rat. Proceedings of the National Academy of Science, USA. 62:1969;741-748.
5. 4 receptor subtype involvement in the enhancement of striatal dopamine release induced by serotonin: a microdialysis study in the halothane-anesthetized rats. Neuropharmacology. 34:1995;269-279.
6. Broderick P.A., Piercey M.F. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release. Journal of Neural Transmission. 105:1998;749-767.
7. Brun P., Steinberg R., Le Fur G., Soubrié P. Blockade of neurotensin receptor by SR 48692 potentiates the facilitatory effect of haloperidol on the evoked in vivo dopamine release in the rat nucleus accumbens. Journal of Neurochemistry. 64:1995;2073-2079.
8. Bunney B.S., Walters J.R., Roth R.H., Aghajanian G.K. Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. Journal of Pharmacology and Experimental Therapeutics. 185:1973;560-571.
9. Clark R.N., Ashby C.R. Jr., Dewey S.L., Veeraraghavan-Ramachandran P., Strecker R.E. Effect of acute and chronic fluoxetine on extracellular dopamine levels in the caudate-putamen and nucleus accumbens of rat. Synapse. 23:1996;125-131.
10. Corvaja N., Doucet G., Bolam J.P. Ultrastructure and synaptic targets of the raphe-nigral projection in the rat. Neuroscience. 55:1993;417-427.
11. Cudennec A., Duverger D., Serrano A., Scatton B., McKenzie E.T. Influence of ascending serotonergic pathways on glucose use in the conscious rat brain. II. Effects of electrical stimulation of the rostral raphe nuclei. Brain Research. 444:1988;227-246.
12. De Deurwaerdère P., Bonhomme N., Le Moal M., Spampinato U. d-Fenfluramine increases striatal extracellular dopamine independently of serotonergic terminals or dopamine uptake sites. Journal of Neurochemistry. 65:1995;1100-1108.
13. De Deurwaerdère P., Bonhomme N., Lucas G., Le Moal M., Spampinato U. Serotonin enhances striatal dopamine outflow in vivo through dopamine uptake sites. Journal of Neurochemistry. 66:1996;210-215.
14. 4 receptors indirectly enhances in vivo dopamine release in the rat striatum. Journal of Neurochemistry. 68:1997;195-203.
15. 3 receptors. Journal of Neuroscience. 18:1998;6528-6538.
16. 2B/2C receptor subtypes in the control of accumbal and striatal dopamine release elicited in vivo by dorsal raphe nucleus electrical stimulation. Journal of Neurochemistry. 73:1999;1033-1042.
17. Dewey S.L., Smith G.S., Logan J., Alexof D., Ding Y., King P., Pappas N., Brodie J.D., Ashby C.R. Serotonergic modulation of striatal dopamine measured with positon emission tomography (PET) and in vivo microdialysis. Journal of Neuroscience. 15:1995;821-829.
18. Di Giovanni G., De Deurwaerdère P., Di Mascio M., Di Matteo V., Esposito E., Spampinato U. Selective blockade of serotonin-2C/2B receptors enhances mesolimbic and mesostriatal dopaminergic function: a combined in vivo electrophysiological and microdialysis study. Neuroscience. 91:1999;587-597.
19. Dray A. Serotonin in the basal ganglia: functions and interactions with other neuronal pathways. Journal of Physiology Paris. 77:1981;393-403.
20. Ennis C., Kemp J.D., Cox B. Characterization of inhibitory 5-hydroxytryptamine receptors that modulate dopamine release in the striatum. Journal of Neurochemistry. 36:1981;1515-1520.
21. Feuerstein T.J., Hertting G., Lupp A., Neufang B. False labelling of dopaminergic terminals in the rabbit caudate nucleus: uptake and release of [3H]-5-hydroxytryptamine. British Journal of Pharmacology. 88:1986;677-684.
22. 3H]DOPA in various regions of the brain. Journal of Neurochemistry. 13:1966;655-669.
23. 2 agonists. European Journal of Pharmacology. 264:1994;325-330.
24. Gundlah C., Hjorth S., Auerbach S.B. Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment. Neuropharmacology. 36:1997;475-482.
25. 1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor. Neuropharmacology. 36:1997;461-465.
26. 1A receptor agonist, inhibits amphetamine-induced dopamine release in vivo in rat striatum and nucleus accumbens. European Journal of Pharmacology. 287:1995;179-184.
27. 2A/2C agonist, potentiates amphetamine-induced dopamine release in rat striatum. Brain Research. 698:1995;204-208.
28. Jacocks H.M., Cox B.M. Serotonin-stimulated release of (3H)-dopamine via reversal of the dopamine transporter in rat striatum and nucleus accumbens: a comparison with release elicited by potassium, N-methyl-d-aspartic acid, glutamic acid and d-amphetamine. Journal of Pharmacology and Experimental Therapeutics. 262:1992;356-364.
29. James T.A., Starr M.S. Rotational behaviour elicited by 5-HT in the rat: evidence for an inhibitory role of 5-HT in the substantia nigra and corpus striatum. Journal of Pharmacology. 32:1980;196-200.
30. Kalén P., Strecker R.E., Rosengren E., Björklund A. Endogenous release of neuronal serotonin and 5-hydroxyindoleacetic acid in the caudate-putamen of the rat as revealed by intracerebral dialysis coupled to high-performance liquid chromatography with fluorimetric detection. Journal of Neurochemistry. 51:1988;1422-1435.
31. Kelland M.D., Chiodo L.A., Freeman A.S. Dissociative anesthesia and striatal neuronal electrophysiology. Synapse. 9:1991;75-78.
32. Kirby L.G., Kreiss D.S., Singh A., Lucki I. Effect of destruction of serotonin neurons on basal and fenfluramine-induced serotonin release in striatum. Synapse. 20:1995;99-105.
33. Koch S., Uhde M.A., Galloway M.P. Serotonin facilitation of dopamine release after inhibition of serotonin reuptake. 28th Annual Meeting of the Society of Neuroscience, vol. 24. 1998;48.6. (abstract).
34. Kreiss D.F., Wieland S., Lucki I. The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release. Neuroscience. 52:1993;295-301.
35. Lidsky T.I., Banerjee S.P. Acute administration of haloperidol enhances dopaminergic transmission. Journal of Pharmacology and Experimental Therapeutics. 265:1993;1193-1198.
36. 2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release. Psychopharmacology. 131:1997;57-63.
37. 2C receptor subtypes in the control of dopamine release in the rat striatum. Abercrombie E., Rollema H. Monitoring Molecules in Neurosciences, 8th International Conference on in vivo Methods. 1999;240-241. (abstract).
38. 2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum. Journal of Neurochemistry. 74:2000;693-701.
39. 2C receptor subtypes and significance of hapoleridol dose used. Neuropharmacology, in press.
40. 2 receptor in apomorphine-induced facilitation of forebrain serotonin output. European Journal of Pharmacology. 351:1998;291-298.
41. Mereu G., Fanni B., Gessa G.L. General anesthetics prevent dopaminergic neuron stimulation by neuroleptics. Catecholamines: Neuropharmacology and Central Nervous System - Theoretical Aspects. 1984;353-358 Alan R. Liss Inc. New York.
42. 2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo. Neuropharmacology. 37:1998;953-955.
43. Moukhles H., Bosler O., Bolam J.P., Valle A., Umbriaco D., Geffard M., Doucet G. Quantitative and morphometric data indicate precise cellular interactions between serotonin and postsynaptic targets in rat substantia nigra. Neuroscience. 76:1997;1159-1171.
44. 2 antagonists and minaprine block the 5-HT-induced inhibition of dopamine release from rat strital slices. European Journal of Pharmacology. 153:1988;89-95.
45. Nedergaard S., Bolam J.P., Greenfield S.A. Facilitation of a dendritic calcium conductance by 5-hydroxytryptamine in the substantia nigra. Nature. 333:1988;174-177.
46. 2C receptor. Psychopharmacology. 126:1996;234-240.
47. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed. 1986;Academic Press, New York.
48. Perry K.W., Fuller R.W. Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Science. 50:1992;183-190.
49. Pozzi L., Invernizzi R., Garavaglia C., Samanin R. Fluoxetine increases extracellular dopamine in the prefrontal cortex by a mechanism not dependent on serotonin: a comparison with citalopram. Journal of Neurochemistry. 73:1999;1051-1057.
50. 1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors. Journal of Neurochemistry. 68:1997;2593-2603.
51. 2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine. European Journal of Pharmacology. 223:1992;65-74.
52. 2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine. Journal of Neurochemistry. 62:1994;1382-1389.
53. Schotte A., Janssen P.F.M., Megens A.A.H.P., Leysen J.E. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Research. 631:1993;191-202.
54. Sørensen K., Brodbeck U. A sensitive protein assay method using micro-titer plates. Experimentia. 42:1986;161-162.
55. Soghomonian J.J., Descarries L., Watkins K. Serotonin innervation in adult rat neostriatum. II. Ultrastructural features: a radioautographic and immunocytochemical study. Brain Research. 481:1989;67-86.
56. Soubrié P., Reisine T.D., Glowinski J. Functional aspects of serotonin transmission in the basal ganglia: a review and an in vivo approach using the push-pull cannula technique. Neuroscience. 13:1984;605-625.
57. Spampinato U., Girault J.A., Danguir J., Savaki H.E., Glowinski J., Besson M.J. Apomorphine and haloperidol effects on striatal dopamine release in anasthetized, awake, restrained and freely moving rats. Brain Research Bulletin. 16:1986;161-166.
58. Westfall C., Tittermary V. Inhibition of the electrically induced release of [3H]dopamine by serotonin from superfused rat striatal slices. Neuroscience Letters. 28:1982;205-209.
59. Wong P.T.H., Feng H., Teo W.L. Interaction of the dopaminergic and serotonergic systems in the rat striatum: effects of selective antagonists and uptake inhibitors. Neuroscience Research. 23:1995;115-119.
60. Yadid G., Karel P., Kopin I.J., Goldstein D.S. Endogenous serotonin stimulates striatal dopamine release in conscious rats. Journal of Pharmacology and Experimental Therapeutics. 270:1994;1158-1165.
61. 3H] dopamine release from rat striatal synaptosomes. European Journal of Pharmacology. 199:1991;185-189.